2nd Quarter - Report

W STRATEGIES, LLC for ALEXION PHARMACEUTICALS

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Education about the value of innovative new medicines and the Orphan Drug Act. H.R.1231/S.456: RACE for Children Act. H.R.2430/S.934: FDA Reauthorization Act of 2017. Education about the 340(b)m program. H.R.3472: Access to Marketplace Insurance Act. S. 204: Trickett Wendler Right to Try Act of 2017. H.R. 1628: American Health Care Act. Better Care Reconciliation Act.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 204 (115th), S. 934 (115th), S. 456 (115th), H.R. 1628 (115th), H.R. 1231 (115th), H.R. 3472 (115th), H.R. 2430 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.